AAM noted that its members have worked hard to enhance patient access to affordable treatments, such as manufacturing dexamethasone, throughout the pandemic.
Teva won a U.S. appeals court ruling that upheld three patents on its Ajovy migraine drug, though six other patents on the treatment were ruled invalid, according to a report.
Vgyaan received the Food and Drug Administration’s approval for ursodiol capsules, and launched its Nadolol tablets and clomipramine hydrochloride capsules.